Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Esther Frimpong"'
Autor:
Andriana Inkoom, Nkafu Bechem Ndemazie, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary Poku, Xue Zhu, Bo Han, Jose Trevino, Edward Agyare
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-21 (2023)
Abstract Gemcitabine (Gem) has been a standard first-line drug for pancreatic cancer (PCa) treatment; however, Gem's rapid metabolism and systemic instability (short half-life) limit its clinical outcome. The objective of this study was to modify Gem
Externí odkaz:
https://doaj.org/article/b2cc55ae94fe4dfebec37f5fa558de10
Autor:
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino, Bo Han, Xue Zhu, Edward Agyare
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract The failure of current chemotherapeutic agents for pancreatic cancer (PCa) makes it the most aggressive soft tissue tumor with a 5-year survival of slightly above 10% and is estimated to be the second leading cause of cancer death by 2030. O
Externí odkaz:
https://doaj.org/article/de7ab34d17cb45a396ffc170597f2349
Publikováno v:
Health Psychology Open, Vol 7 (2020)
The use of various forms of contraception in Ghana gained prominence after the government resorted to investing more in family planning programs when maternal mortality was declared an emergency in the country. In Ghana, the intention to use and actu
Externí odkaz:
https://doaj.org/article/ce28513bdc6546f9bbca86bd5c729000
Autor:
Guettchina Telisnor, David L. DeRemer, Esther Frimpong, Edward Agyare, John Allen, Luisel Ricks-Santi, Bo Han, Thomas George, Sherise C. Rogers
Publikováno v:
Journal of the National Medical Association. 115:164-174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::593ee65d3709f9280bac66ab7c414470
https://doi.org/10.1016/j.jnma.2023.01.008
https://doi.org/10.1016/j.jnma.2023.01.008
Autor:
Andriana Inkoom, Nkafu Ndemazie, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary Poku, Xue Zhu, Bo Han, Jose Trevino, Edward Agyare
Purpose: Gemcitabine (Gem) remains a preferred first-line anticancer drug used for the treatment of pancreatic cancer (PCa). However, rapid metabolism and systemic instability (short half-life) have limited its therapeutic efficacy. The purpose of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7adf37be17c94e59b586c89f856c41d0
https://doi.org/10.21203/rs.3.rs-1777458/v1
https://doi.org/10.21203/rs.3.rs-1777458/v1
Autor:
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino, Bo Han, Xue Zhu, Edward Agyare
The failure of current chemotherapeutic agents for pancreatic cancer (PCa) makes it the most aggressive soft tissue tumor with a 5-year survival of slightly above 10% and is estimated to be the second leading cause of cancer death by 2030. Objective:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abe428520a726035caf2ec7cdd57a9eb
https://doi.org/10.21203/rs.3.rs-1863111/v1
https://doi.org/10.21203/rs.3.rs-1863111/v1
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C026-C026
Background Pancreatic Ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer mortality and is projected to increase in incidence by 2030 in the United States. Compared to Caucasians, African Americans (AA) have a significantly in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cf47af8c84499feb6fabd3a73682612
https://doi.org/10.1158/1538-7755.disp22-c026
https://doi.org/10.1158/1538-7755.disp22-c026
Publikováno v:
Psychological reports.
Depression affects over 17 million American adults yearly and has been identified as the leading cause of disability in people between the ages of 15 and 44 years. There is evidence that feeling neglect or a lack of parental attachment during childho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef7adad658ea706ef47995a1c56466d7
https://pubmed.ncbi.nlm.nih.gov/34969338
https://pubmed.ncbi.nlm.nih.gov/34969338